rac-(2S,4R)-2-cyclopropyl-4-piperidinol hydrochloride, 95.0%, 1g

Methyl 7-methoxy-1H-indole-2-carboxylate, 98%, 10g

(1-(4-Aminophenyl)piperidin-4-yl)methanol, 95%, 1g

7-tert-Butyl 3-ethyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3,7-dicarboxylate, 98%, 1g

N-Boc-D-glutamic acid 1-methyl ester, 95.0%, 5g

Methyl 3-(p-tolyl)propanoate, 98%, 1g

ETHYL 3-(4-HYDROXYPHENYL)-5-METHYLISOXAZOLE-4-CARBOXYLATE, 97.0%, 250mg

Ethyl 2-chloro-5-nitronicotinate, 95.0%, 5g

Lithium Formate Monohydrate>98.0%(T)500g

ETHYL 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 1g

monoclonal de ratón anti-queratina K19, Ks19.2 (Z105.6), 1 ml

tert-Butyl (5-(hydroxymethyl)pyridin-2-yl)carbamate, 95.0%, 5g

(6-(Difluoromethyl)pyridin-2-yl)methanol, 98%, 1g